# Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients

> **NCT02178540** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 45 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Placebo
- **DEVICE:** Tobi Podhaler

## Key facts

- **NCT ID:** NCT02178540
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2016-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02178540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02178540, "Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02178540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*